Literature DB >> 2902502

Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat.

T Shibasaki1, N Yamauchi, Y Kato, A Masuda, T Imaki, M Hotta, H Demura, H Oono, N Ling, K Shizume.   

Abstract

The mechanism by which restraint stress induces suppression of food intake and the influence of intracerebroventricular (icv) administration of somatostatin on the anorexia induced by restraint stress were examined in the rat. Ninety minutes of restraint stress reduced food intake of rats to approximately 60% that of control. Anorexia induced by 90 min restraint stress was partially reversed by icv administration of alpha-helical CRF (9-41), a corticotropin-releasing factor (CRF) antagonist, and completely reversed by anti-CRF gamma-globulin. These results provide further evidence in support of the theory that CRF is involved in the inhibitory mechanism of food intake in restraint stress. ICV administration of somatostatin 14 and SMS 201-995, an analog of somatostatin, also reversed restraint stress-induced anorexia. It is, therefore, suggested that somatostatin may counteract the suppressive action of CRF on food intake in stress.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902502     DOI: 10.1016/0024-3205(88)90468-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder.

Authors:  J D Bremner; J Licinio; A Darnell; J H Krystal; M J Owens; S M Southwick; C B Nemeroff; D S Charney
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

Review 2.  Appetite regulation: the role of peptides and hormones.

Authors:  J E Morley
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

3.  Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis.

Authors:  A Tabarin; Y Diz-Chaves; D Consoli; M Monsaingeon; T L Bale; M D Culler; R Datta; F Drago; W W Vale; G F Koob; E P Zorrilla; A Contarino
Journal:  Eur J Neurosci       Date:  2007-10       Impact factor: 3.386

4.  Footshock-induced freezing behavior in rats as a model for assessing anxiolytics.

Authors:  L H Conti; C R Maciver; J W Ferkany; M E Abreu
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.

Authors:  Martin A Sticht; David J Lau; Catherine M Keenan; Jean-Baptiste Cavin; Maria Morena; Venkata Kiran Vemuri; Alexandros Makriyannis; Benjamin F Cravatt; Keith A Sharkey; Matthew N Hill
Journal:  Br J Pharmacol       Date:  2018-08-22       Impact factor: 8.739

Review 6.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 7.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

8.  Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats.

Authors:  S C Heinrichs; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  How Does the Brain Implement Adaptive Decision Making to Eat?

Authors:  Valérie Compan; B Timothy Walsh; Walter Kaye; Allan Geliebter
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.